Antibiotic associated diarrhea in outpatient pediatric antibiotic therapy
dc.contributor.author | Basaranoglu, ST | |
dc.contributor.author | Karaaslan, A | |
dc.contributor.author | Sali, E | |
dc.contributor.author | Çiftçi, E | |
dc.contributor.author | Aydin, ZGG | |
dc.contributor.author | Kocabas, BA | |
dc.contributor.author | Kaya, C | |
dc.contributor.author | Bayturan, SS | |
dc.contributor.author | Kara, SS | |
dc.contributor.author | Çiftdogan, DY | |
dc.contributor.author | Çay, Ü | |
dc.contributor.author | Aktürk, HG | |
dc.contributor.author | Çelik, M | |
dc.contributor.author | Ozdemir, H | |
dc.contributor.author | Somer, A | |
dc.contributor.author | Diri, T | |
dc.contributor.author | Yazar, AS | |
dc.contributor.author | Sütçü, M | |
dc.contributor.author | Tezer, H | |
dc.contributor.author | Oncel, EK | |
dc.contributor.author | Kara, M | |
dc.contributor.author | Çelebi, S | |
dc.contributor.author | Parlakay, AÖ | |
dc.contributor.author | Karakaslilar, S | |
dc.contributor.author | Arisoy, ES | |
dc.contributor.author | Tanir, G | |
dc.contributor.author | Kara, TT | |
dc.contributor.author | Devrim, I | |
dc.contributor.author | Erat, T | |
dc.contributor.author | Aykaç, K | |
dc.contributor.author | Kaba, Ö | |
dc.contributor.author | Güven, S | |
dc.contributor.author | Yesil, E | |
dc.contributor.author | Yilmaz, AT | |
dc.contributor.author | Durmus, SY | |
dc.contributor.author | Çaglar, I | |
dc.contributor.author | Günay, F | |
dc.contributor.author | Özen, M | |
dc.contributor.author | Dinleyici, EÇ | |
dc.contributor.author | Kara, A | |
dc.date.accessioned | 2024-07-18T12:08:19Z | |
dc.date.available | 2024-07-18T12:08:19Z | |
dc.description.abstract | BackgroundAntibiotic-associated diarrhea is one of the most frequent side effects of antimicrobial therapy. We assessed the epidemiological data of antibiotic-associated diarrhea in pediatric patients in our region.MethodsThe prospective multi-center study included pediatric patients who were initiated an oral antibiotic course in outpatient clinics and followed in a well-established surveillance system. This follow-up system constituded inclusion of patient by the primary physician, supply of family follow-up charts to the family, passing the demographics and clinical information of patient to the Primary Investigator Centre, and a close telephone follow-up of patients for a period of eight weeks by the Primary Investigator Centre.ResultsA result of 758 cases were recruited in the analysis which had a frequency of 10.4% antibiotic-associated diarrhea. Among the cases treated with amoxicillin-clavulanate 10.4%, and cephalosporins 14.4% presented with antibiotic-associated diarrhea. In the analysis of antibiotic-associated diarrhea occurrence according to different geographical regions of Turkey, antibiotic-associated diarrhea episodes differed significantly (p = 0.014), particularly higher in The Eastern Anatolia and Southeastern Anatolia. Though most commonly encountered with cephalosporin use, antibiotic-associated diarrhea is not a frequent side effect.ConclusionThis study on pediatric antibiotic-associated diarrhea displayed epidemiological data and the differences geographically in our region. | |
dc.identifier.other | 1471-2431 | |
dc.identifier.uri | http://akademikarsiv.cbu.edu.tr:4000/handle/123456789/10887 | |
dc.language.iso | English | |
dc.publisher | BMC | |
dc.subject | GUT MICROBIOTA | |
dc.subject | IMPACT | |
dc.title | Antibiotic associated diarrhea in outpatient pediatric antibiotic therapy | |
dc.type | Article |